FMR LLC 13D and 13G filings for United Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,321,039 4.939% | -265,765 (-10.27%) | Filing |
| 2023-02-09 12:39 pm Purchase | 2023-02-09 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,586,804 5.675% | 63,426 (+2.51%) | Filing |
| 2022-02-09 10:01 am Purchase | 2022-02-08 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,523,378 5.602% | 200,695 (+8.64%) | Filing |
| 2021-02-08 10:35 am Sale | 2021-02-05 | 13G | United Therapeutics Corporation UTHR | FMR LLC | 2,322,683 5.226% | -60,866 (-2.55%) | Filing |